Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated:  2/26/2016
South Texas Oncology and Hematology
mi
from
San Antonio, TX
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer
Status: Enrolling
Updated: 2/26/2016
South Texas Oncology and Hematology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
GenomeDx Decipher Test for Metastatic Disease Prognosis in Prostate Cancer for Patients With Adverse Pathology Post Radical Prostatectomy: Does it Impact Radiation Oncologist' Treatment Recommendations?
Status: Enrolling
Updated:  2/26/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists
GenomeDx Decipher Test for Metastatic Disease Prognosis in Prostate Cancer for Patients With Adverse Pathology Post Radical Prostatectomy: Does it Impact Radiation Oncologist' Treatment Recommendations?
Status: Enrolling
Updated: 2/26/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
UCSD Moores Cancer Center
mi
from
La Jolla, CA
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
UCSD Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Sharp Clinical Oncology Research
mi
from
San Diego, CA
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Sharp Clinical Oncology Research
mi
from
San Diego, CA
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Georgetown University Medical Center
mi
from
Washington,
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Indiana University
mi
from
Indianapolis, IN
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Mount Sinai School of Medicine
mi
from
New York, NY
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Columbia University Medical Center
mi
from
New York, NY
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Providence Medical Center
mi
from
Portland, OR
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Providence Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Kaiser Permanente
mi
from
Portland, OR
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Kaiser Permanente
mi
from
Portland, OR
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Northwest Cancer Specialists, Pc
mi
from
Portland, OR
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Northwest Cancer Specialists, Pc
mi
from
Portland, OR
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Urology of Virginia, Sentara Medical Group
mi
from
Norfolk, VA
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Urology of Virginia, Sentara Medical Group
mi
from
Norfolk, VA
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Virginia Mason Medical Center Urology and Renal Transplantation
mi
from
Seattle, WA
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Virginia Mason Medical Center Urology and Renal Transplantation
mi
from
Seattle, WA
Click here to add this to my saved trials
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated:  2/29/2016
Seattle Cancer Care Alliance
mi
from
Seattle, WA
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Status: Enrolling
Updated: 2/29/2016
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Birmingham Hematology and Oncology Associates, LLC
mi
from
Birmingham, AL
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Birmingham Hematology and Oncology Associates, LLC
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Ironwood Cancer and Research
mi
from
Chandler, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Ironwood Cancer and Research
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Palo Verde Cancer Specialists
mi
from
Glendale, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Palo Verde Cancer Specialists
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Weatern Regional Medical Center / Cancer Treatment Centers of America
mi
from
Goodyear, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Weatern Regional Medical Center / Cancer Treatment Centers of America
mi
from
Goodyear, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Pinnacle Oncology Hematology, Oncology Research Associates, PLLC
mi
from
Scottsdale, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Pinnacle Oncology Hematology, Oncology Research Associates, PLLC
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
21st Century Oncology
mi
from
Scottsdale, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
21st Century Oncology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Arizona Oncology Associates, PC - HOPE
mi
from
Tucson, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Arizona Oncology Associates, PC - HOPE
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Urological Associates of Southern Arizona, PC
mi
from
Tucson, AZ
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Urological Associates of Southern Arizona, PC
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Little Rock Hematology Oncology: A Division of CARTI
mi
from
Little Rock, AR
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Little Rock Hematology Oncology: A Division of CARTI
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
South County Hematology/Oncology
mi
from
Chula Vista, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
South County Hematology/Oncology
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Wilshire Oncology Medical Group, Inc.
mi
from
Pomona, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Wilshire Oncology Medical Group, Inc.
mi
from
Pomona, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Urology Specialists of Southern California
mi
from
Encino, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Urology Specialists of Southern California
mi
from
Encino, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Robert A. Moss, M.D. FACP, Inc.
mi
from
Fountain Valley, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Robert A. Moss, M.D. FACP, Inc.
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Pacific Shores Medical Group
mi
from
Long Beach, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Pacific Shores Medical Group
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
UCSD Medical Center- La Jolla
mi
from
La Jolla, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
UCSD Medical Center- La Jolla
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
UCSD Moores Cancer Center
mi
from
La Jolla, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
UCSD Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Cancer Center Oncology Medical Group
mi
from
La Mesa, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Cancer Center Oncology Medical Group
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
UCLA Institute of Urologic Oncology, UCLA Medical Center
mi
from
Los Angeles, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
UCLA Institute of Urologic Oncology, UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Tower Urology
mi
from
Los Angeles, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Tower Urology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Prostate Oncology Speciality Inc.
mi
from
Marina del Rey, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Prostate Oncology Speciality Inc.
mi
from
Marina del Rey, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
North County Oncology Medical Group, Inc.
mi
from
Oceanside, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
North County Oncology Medical Group, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Hematology-Oncology Medical Group of Orange County, Inc.
mi
from
Orange, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Hematology-Oncology Medical Group of Orange County, Inc.
mi
from
Orange, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
The Center for Cancer Prevention & Treatment at St. Joseph Hospital
mi
from
Orange, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
The Center for Cancer Prevention & Treatment at St. Joseph Hospital
mi
from
Orange, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Medical Oncology Care Associates (MOCA)
mi
from
Orange, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Medical Oncology Care Associates (MOCA)
mi
from
Orange, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
PMK Medical Group, Inc., dba Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
PMK Medical Group, Inc., dba Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Sutter Roseville Medical Center
mi
from
Roseville, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Sutter Roseville Medical Center
mi
from
Roseville, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Sutter Cancer Center / Sacramento Center for Hematology and Medical Oncology
mi
from
Sacramento, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Sutter Cancer Center / Sacramento Center for Hematology and Medical Oncology
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Sutter Memorial Hospital
mi
from
Sacramento, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Sutter Memorial Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Sharp Clinical Oncology Research
mi
from
San Diego, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Sharp Clinical Oncology Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Sharp Rees-Stealy
mi
from
San Diego, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Sharp Rees-Stealy
mi
from
San Diego, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Genesis Research
mi
from
San Diego, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Genesis Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Medical Oncology Associates
mi
from
San Diego, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Medical Oncology Associates
mi
from
San Diego, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
UCSD Medical Center - Hillcrest
mi
from
San Diego, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
UCSD Medical Center - Hillcrest
mi
from
San Diego, CA
Click here to add this to my saved trials
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated:  2/29/2016
Edward Alexson, Md, Inc.
mi
from
Santa Ana, CA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Status: Enrolling
Updated: 2/29/2016
Edward Alexson, Md, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials